Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-08

Clinical Trial Update: Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update examining whether amlodipine-folic acid tablets reduce blood pressure and plasma homocysteine in essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine-Folic Acid Tablets (amlodipine; folic acid)

Snippet

Sponsor: Shenzhen Ausa Pharmed Co.,Ltd | Conditions: Essential Hypertension | Phase 2, Phase 3 | Status: UNKNOWN